OMADA HEALTH, INC. COMMON STOCK

NASDAQ: OMDA (Omada Health, Inc.)

最近更新时间: 5小时之前

11.87

-0.63 (-5.04%)

前收盘价格 12.50
成交量 1,711,571
平均成交量 (3个月) 1,328,329
市值 736,387,776
市盈率 (P/E TTM) 29.68
预期市盈率 (P/E Forward) 35.97
价格/销量 (P/S) 2.25
股市价格/股市净资产 (P/B) 2.69
52周波幅
10.28 (-13%) — 25.45 (114%)
利润日期 5 Nov 2026
营业毛利率 4.21%
营业利益率 (TTM) 2.06%
稀释每股收益 (EPS TTM) 0.400
季度收入增长率 (YOY) 34.20%
总债务/股东权益 (D/E MRQ) 50.99%
流动比率 (MRQ) 4.18
营业现金流 (OCF TTM) 28.69 M
杠杆自由现金流 (LFCF TTM) 16.94 M
资产报酬率 (ROA TTM) 1.35%
股东权益报酬率 (ROE TTM) 5.72%

AIStockmoo 评分

-0.6
负债低。盈利能力弱。短期流动性充足。现金流为正。 参考
来自我们的 AI Insight 报告对预期回报与风险的评估。 参考 NA
相对估值 参考 NA
隐含增长 参考 NA
历史估值 参考 NA
资本回报 参考 NA
持仓估值 参考 NA
风险溢价 参考 NA
市场估值 参考 NA
过去一年没有明确趋势。股价远低于52周高点。 参考
下降趋势:股价位于均线之下,均线向下。股价已大幅低于均线。下跌日成交量较大。 参考
来自我们对走势图的 AI 技术分析。 参考 NA
K线形态 参考 NA
近期新闻大多正面。 参考
分析师共识 参考 NA
持仓情绪 参考 NA
机构在最新13F申报中净-4.49%的股份:153家增持,50家减持(截至30 Sep 2026的季度)。 参考
空头持仓从31 Aug到30 Oct 2026变化+59.6%,回补天数11.4天(FINRA)。 参考
内部交易活动 参考 NA
市场环境偏谨慎。 参考
行业对比大市 (6个月) NA
各支柱方向不一,评分因此减弱。
每股盈利逐年上升。近年曾亏损。 参考
低于中期趋势线。 参考
股价低于其52周平均水平。5年来下跌。 参考
短、中、长期趋势均向下。短期动能下降。 参考
支撑与阻力没有明确信号。 参考
最终评分 -0.61
全部展开

内部持股比例 2.12%
机构持股比例 95.66%

所有权

姓名 日期 持有股份
Divisadero Street Capital Management, Lp 30 Sep 2026 4,320,160
Cigna Investments Inc /New 30 Sep 2026 3,444,629
Estuary Capital Management Lp 30 Sep 2026 1,338,791
Oberweis Asset Management Inc/ 30 Sep 2026 1,216,266

该时间范围内无数据。

机构

机构持股比例: 94.44%

持仓变动 机构数 股数
增持 153 18,822,397
减持 50 14,111,162
新建仓 63 3,843,683
清仓 19 11,338,750

来源:经Nasdaq的SEC 13F申报,最新申报截至30 Sep 2026。申报在每季结束后45天内陆续提交。

空头持仓

结算日 股数 回补天数
30 Oct 2026 9,163,783 11.4
15 Oct 2026 8,346,222 6.7
30 Sep 2026 7,452,573 4.4
15 Sep 2026 7,470,777 5.9
31 Aug 2026 5,742,536 6.5
14 Aug 2026 5,887,161 3.1

来源:经Nasdaq的FINRA空头持仓数据,每月公布两次。

8 正面 1 负面 3 中性
日期 类型 细节
16 Nov 2026 Yahoo Finance Omada Health Presents AI-Powered Meal Feedback Research and 12-Month GLP-1 Care Track Outcomes at ObesityWeek 2026
Omada’s AI-powered Meal Map tool, built to focus on nutrient quality rather than restrictive eating, helped members build meal-tracking habits linked to greater weight loss at week 16. In Omada’s GLP-1 Care Track, 71% of members stayed on their medication for a full year, and those who did lost…
08 Nov 2026 Yahoo Finance Omada: 3 Key Takeaways for Long-Term Investors
Omada's cost to serve fell to an all-time low, and it has seemingly found a way to profit from GLP-1 drugs whether employers pay for them or not.
08 Nov 2026 Yahoo Finance What Changes For Omada Health (OMDA) As It Names A New CEO?
Omada Health (NasdaqGS:OMDA) reported record Q3 results and raised full year revenue guidance on 6 November 2026. Co Founder Sean Duffy will shift from CEO to Executive Chair as part of a planned leadership change. Wei Li Shao is set to take over as Chief Executive Officer in January 2027, pending…
08 Nov 2026 Yahoo Finance Omada Health (OMDA) Stock May Be Fully Priced Following Raised Guidance
Omada Health has seen its stock lose ground in recent weeks, and that pullback now puts a spotlight on a simple question for investors who care about fundamentals: Is the current share price properly reflecting what the company is earning today and what those earnings may reasonably support over…
07 Nov 2026 Yahoo Finance Omada Health (OMDA) Dropped, So What Is Behind The Attention Now?
Omada Health (OMDA) drew fresh attention on 5 November 2026 after lifting full year 2026 revenue guidance to US$344 million to US$346 million, following what management described as its strongest quarter so far. Despite the stronger outlook and record third quarter, Omada Health shares closed at…
06 Nov 2026 Yahoo Finance Omada Health (OMDA) Q3 2026 Earnings Call Transcript
Member tenure rose sharply as a CEO handoff approaches for 2027…
06 Nov 2026 Yahoo Finance Omada Health Q3 2026 Earnings Call Summary
Moby summary of Omada Health's Q3 2026 earnings call…
06 Nov 2026 Yahoo Finance What Omada Health (OMDA) Said on Its Q3 Earnings Call
Omada Health (NASDAQ:OMDA) raised its full-year 2026 revenue and adjusted EBITDA outlook after reporting record quarterly revenue and net income in the third quarter, driven by enrollment and growth in its diabetes and hypertension programs. Revenue rose 34% year over year to $91 million, while net…
06 Nov 2026 Yahoo Finance Omada Health Inc (OMDA) (Q3 2026) Earnings Call Highlights: Record Revenue, Membership Growth, ...
Omada Health Inc (OMDA) delivered its strongest quarter ever with 34% revenue growth, record profitability, and improved member retention, prompting an upward revision of full-year 2026 guidance.
05 Nov 2026 Yahoo Finance Compared to Estimates, Omada Health, Inc. (OMDA) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Omada Health, Inc. (OMDA) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
05 Nov 2026 Yahoo Finance Omada Health, Inc. (OMDA) Q3 Earnings and Revenues Beat Estimates
Omada Health, Inc. (OMDA) delivered earnings and revenue surprises of +88.89% and +6.48%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
05 Nov 2026 Yahoo Finance Omada Health Reports Third Quarter 2026 Results
Quarterly Revenue of $91 million and All-Time High Total Members of 1.1 millionRevenue Grew 34% and Total Members Increased 36% Year over YearRaises Full Year 2026 Financial Outlook SAN FRANCISCO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Omada Health, Inc. (Nasdaq: OMDA), the virtual between-visit…
22 Oct 2026 Yahoo Finance PRISM MarketView Highlights Five Innovative Public Companies Supporting Strength and Mobility for National Physical Therapy Month
OrthoPediatrics, Omada Health, Enovis, Myomo and FIGS span the full arc of physical therapy, from childhood care and prevention to recovery and the professionals who deliver it NEW YORK, Oct. 22, 2026 (GLOBE NEWSWIRE) -- PRISM MarketView, a financial media platform covering small and micro-cap…
20 Oct 2026 Yahoo Finance Omada Health to Present Peer-Reviewed Research on Improving Weight Loss and Body Composition During GLP-1 Treatment at World Obesity and Weight Management Congress
The oral presentation will share results from a 12-week comparative study showing that Omada GLP-1 Care Track members, on average, lost more weight and saw greater improvements in body composition than controlsSAN FRANCISCO, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual…
13 Oct 2026 Yahoo Finance Omada Health to Announce Third Quarter 2026 Financial Results and Host Conference Call on November 5, 2026
SAN FRANCISCO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its third quarter 2026 results on Thursday, November 5, 2026, after market close, and host a conference call to review the results at…
09 Oct 2026 Yahoo Finance Is Omada Health (OMDA) Cheap As Investors Question Its Long Term Targets?
Omada Health (OMDA) drew fresh attention after its recent share price slide, with the stock down about 6% over the past month and roughly 11% over the past 3 months. Measured over a longer stretch, Omada Health shows a mixed picture, with a strong year to date share price return of 39.73% but a 1…
23 Sep 2026 Yahoo Finance Omada Health President Wei-Li Shao Sells 9,418 Shares for $236,000
Despite selling over 9,000 shares, the insider still holds 307,372 shares.
10 Sep 2026 Yahoo Finance Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day
Omada expects to continue to grow revenue at least 20% annually, and updates long-term non-GAAP gross margin target to 80% and adjusted EBITDA margin target to 30%SAN FRANCISCO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit healthcare provider…
显示更多

近期信号 K线形态与EMA交叉

▼ 死亡交叉 7个交易日前 · 11 Nov
长期 · EMA 50/200
50日EMA下穿200日EMA,是广受关注的长期趋势转为向下的信号。

技术形态 中期

趋势排列
斜率
入场位置 –
成交量
下降趋势:股价位于均线之下,均线向下。股价已大幅低于均线。下跌日成交量较大。
最近支撑: 10.93 – 12.05 · 强
最近阻力: 12.88 – 14.15 · 强

AI 技术分析

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

风险 / 回报
TP1:
TP2:

以入场价计算,止损的亏损相对每个目标价的盈利。通常追求 2 或以上的比率。

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2026 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票